Hemodialysis Reliable Outflow (HeRO) graft creation in upper extremities abandoned due to stent obstruction via recanalization and HeRO outflow component insertion across stent interstices.

HeRO graft Hemodialysis Reliable Outflow central venous recanalization stent occlusion venous stent

Journal

The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729

Informations de publication

Date de publication:
10 Dec 2021
Historique:
entrez: 11 12 2021
pubmed: 12 12 2021
medline: 12 12 2021
Statut: aheadofprint

Résumé

The purpose of this study was to assess the feasibility and outcomes of recanalization and subsequent HeRO graft outflow component insertion across stent interstices in patients with an otherwise abandoned upper extremity. Over a 10-year period, 15 patients underwent central venous recanalization by interventional radiology across the interstices of one or more occluded stents for the purpose of subsequent HeRO graft creation. A tunneled central venous catheter was left across the stent and occlusions with tip in right atrium. On a later date, the catheter was used for rapid guidewire access for HeRO graft implantation in the OR by vascular surgery. Procedural and clinical outcomes were determined by retrospective review. Primary and secondary HeRO graft patency rates were estimated with the Kaplan-Meier technique. The technical success rates of recanalization across stent interstices was 100% (15/15). Between one and four overlapping stent walls were traversed. The technical success of the patients who underwent attempted HeRO graft implantation with outflow component traversing across stent interstices was 91% (11/12). No major complications were encountered with either recanalization or HeRO graft implantation. The primary and secondary HeRO patency rates at 12 months were 64% and 80%, respectively. HeRO graft insertion across stent interstices is feasible and can provide effective permanent AV access; thus, the presence of stents across the subclavian and brachiocephalic veins should not be considered a contraindication.

Sections du résumé

BACKGROUND BACKGROUND
The purpose of this study was to assess the feasibility and outcomes of recanalization and subsequent HeRO graft outflow component insertion across stent interstices in patients with an otherwise abandoned upper extremity.
METHODS METHODS
Over a 10-year period, 15 patients underwent central venous recanalization by interventional radiology across the interstices of one or more occluded stents for the purpose of subsequent HeRO graft creation. A tunneled central venous catheter was left across the stent and occlusions with tip in right atrium. On a later date, the catheter was used for rapid guidewire access for HeRO graft implantation in the OR by vascular surgery. Procedural and clinical outcomes were determined by retrospective review. Primary and secondary HeRO graft patency rates were estimated with the Kaplan-Meier technique.
RESULTS RESULTS
The technical success rates of recanalization across stent interstices was 100% (15/15). Between one and four overlapping stent walls were traversed. The technical success of the patients who underwent attempted HeRO graft implantation with outflow component traversing across stent interstices was 91% (11/12). No major complications were encountered with either recanalization or HeRO graft implantation. The primary and secondary HeRO patency rates at 12 months were 64% and 80%, respectively.
CONCLUSION CONCLUSIONS
HeRO graft insertion across stent interstices is feasible and can provide effective permanent AV access; thus, the presence of stents across the subclavian and brachiocephalic veins should not be considered a contraindication.

Identifiants

pubmed: 34892983
doi: 10.1177/11297298211048061
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11297298211048061

Auteurs

Brendan C Cline (BC)

Division of Interventional Radiology, Duke University Medical Center, Durham, NC, USA.
Humacyte Incorporated, Durham, NC, USA.

Adam Zuchowski (A)

Division of Interventional Radiology, Duke University Medical Center, Durham, NC, USA.

Shawn M Gage (SM)

Physician Assistant Program, Duke University Medical Center, Durham, NC, USA.
InnAVasc Medical, Inc., Durham, NC, USA.

Jonathan G Martin (JG)

Division of Interventional Radiology, Duke University Medical Center, Durham, NC, USA.

James Ronald (J)

Division of Interventional Radiology, Duke University Medical Center, Durham, NC, USA.

Kevin W Southerland (KW)

Division of Vascular and Endovascular Surgery, Duke University Medical Center, Durham, NC, USA.

Jeffrey H Lawson (JH)

Humacyte Incorporated, Durham, NC, USA.
Division of Vascular and Endovascular Surgery, Duke University Medical Center, Durham, NC, USA.

Ellen D Dillavou (ED)

Division of Vascular and Endovascular Surgery, Duke University Medical Center, Durham, NC, USA.

Charles Y Kim (CY)

Division of Interventional Radiology, Duke University Medical Center, Durham, NC, USA.

Classifications MeSH